4.6 Article

Associations of insulin resistance and beta-cell function with abnormal lipid profile in newly diagnosed diabetes

Journal

CHINESE MEDICAL JOURNAL
Volume 135, Issue 21, Pages 2554-2562

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CM9.0000000000002075

Keywords

Beta-cell function; Dyslipidemia; Insulin resistance; Type 1 diabetes; Type 2 diabetes

Funding

  1. National Science and Technology Infrastructure Program [2013BAI09B12, 2015BAI12B13]
  2. National Key R&D Program of China [2016YFC1305000, 2017YFC1309604]

Ask authors/readers for more resources

This study found that high insulin resistance is associated with an increased risk of abnormal lipid metabolism in both type 1 and type 2 diabetes patients, while low beta-cell function is not associated with the risk of abnormal lipid metabolism.
Background:Abnormal lipids are strong predictors of cardiovascular disease in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). However, the potential associations of insulin resistance (IR) and beta-cell function (BCF) with abnormal lipids in newly diagnosed T1DM or T2DM patients are not fully understood.Methods:A cross-sectional survey of 15,928 participants was conducted. Homeostasis model assessment and postprandial C-peptide levels were used to estimate IR and BCF. A restricted cubic spline (RCS) nested in binary logistic regression was used to examine the associations of IR and BCF with abnormal lipids.Results:High triglyceride (TG), low high-density lipoprotein cholesterol, and high low-density lipoprotein cholesterol (LDL-C) accounted for 49.7%, 47.8%, and 59.2% of the participants, respectively. In multivariable analysis, high IR was associated with an increased risk of high TGs (P for trend <0.001) in T1DM and is associated with an elevated risk of high TG and low HDL-C (all P for trend <0.01) in T2DM. Low BCF was not associated with risks of dyslipidemia in patients with T1DM or T2DM after adjustment for potential confounders.Conclusion:High IR had different associations with the risk of dyslipidemia in newly diagnosed T1DM and T2DM patients, suggesting that early treatment that improves IR may benefit abnormal lipid metabolism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available